CX(3)CR1 deficiency confers protection from intimal hyperplasia after arterial injury

Department of Medicine, University of North Carolina at Chapel Hill, USA.
Arteriosclerosis Thrombosis and Vascular Biology (Impact Factor: 5.53). 10/2006; 26(9):2056-62. DOI: 10.1161/01.ATV.0000234947.47788.8c
Source: PubMed

ABSTRACT A functional polymorphism in the chemokine receptor CX3CR1 is associated with protection from vascular diseases including coronary artery disease and internal carotid artery occlusive disease. We investigated the mechanisms by which CX3CR1 may be involved by evaluating the inflammatory response to arterial injury in CX3CR1-deficient animals.
Femoral arteries of CX3CR1-/- and wild-type (WT) mice were injured with an angioplasty guide wire. After 1, 5, 14, and 28 days, arteries were harvested and evaluated by histology, morphometry, and immunohistochemistry. Arterial injury upregulated the CX3CR1 ligand CX3CL1. In CX3CR1-/- compared with WT animals, the incidence of neointima formation was 58% lower (P=0.0017), accompanied by no difference in the area of platelet accumulation at day 1 (P=0.48) but a significant decrease in intimal monocyte infiltration at day 5 (P=0.006), vascular smooth muscle cell (VSMC) proliferation at days 5 and 14, and intimal area at day 28 (P=0.009).
In an endothelial denudation injury model, CX3CR1 deficiency protects animals from developing intimal hyperplasia as a result of decreased monocyte trafficking to the lesion. CX3CR1 deficiency decreases VSMC proliferation and intimal accumulation either directly or indirectly as a result of defective monocyte infiltration.

  • Source
    • "Since blood composition is related to a wide range of disease states [3- 6], we postulated that vascular injury might cause a change of proteins in the blood, which could be used as biomarkers associated with vascular injury. Although pharmacological and genetic approaches have been employed to study the pathological remodeling process after vascular injury [7] [8] [9] [10], recent technological advancements in differential proteomics enable high-throughput screening of the proteome to identify blood proteins associated with CVDs [3] [5] [11] [12] [13]. However, the application of proteomic profiling to identify predictive biomarkers for vascular injury remains limited. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Predictive biomarkers may be beneficial for detecting, diagnosing, and assessing the risk of restenosis and vascular injury. We utilized proteomic profiling to identify protein markers in the blood following vascular injury, and corroborated the differential protein expression with immunological approaches. Rats underwent carotid artery injury, and plasma was collected after 2 or 5 weeks. Proteomic profiling was carried out by two-dimensional differential in-gel electrophoresis. The differentially expressed plasma proteins were identified by mass spectroscopy and confirmed by immunoblotting. Proteomic profiling by two-dimensional differential in-gel electrophoresis and mass spectroscopy revealed plasma proteins that were differentially expressed at 2 weeks after injury. Among the proteins identified included vitamin D binding protein (VDBP), aldolase A (aldo A), and apolipoproteinE (apoE). Immunoblotting results validated a significant reduction in these proteins in the plasma at 2 or 5 weeks after vascular injury, in comparison to control animals without vascular injury. These findings suggest that VDBP, aldo A, and apoE may be biomarkers for vascular injury, which will have important prognostic and diagnostic implications.
    American Journal of Translational Research 02/2011; 3(2):139-48. · 3.23 Impact Factor
  • Source
    • "Reduced neointimal hyperplasia in CXCR3 -/-mice [164] CXCL10 Smaller lesions with fewer T-cells in CXCL10 "
  • Source
    Réanimation 01/2010; 20:358-367. DOI:10.1007/s13546-010-0115-4
Show more